| Code | CSB-MP862061HU |
| Abbreviation | Recombinant Human IL21R protein, partial (Active) |
| MSDS | |
| Size | $102 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
IL-21 signaling through its cognate receptor drives T cell and NK cell differentiation in tumor immunity and autoimmune contexts, making quantitative characterization of this interaction essential for therapeutic development. This mammalian-expressed extracellular domain (aa 20–236) demonstrates a binding affinity of 1.87 nM to human IL-21 as measured by surface plasmon resonance, providing a validated reagent for competitive inhibition assays and blocking antibody screening campaigns. The protein exhibits an EC50 of 16.65–19.49 ng/mL in functional ELISA, supporting its use in ligand-binding studies, therapeutic antibody epitope mapping, and small-molecule inhibitor screening workflows where dose-response precision is critical. Endotoxin levels below 1.0 EU/μg and purity exceeding 95% satisfy the quality thresholds commonly required for SPR, biolayer interferometry, and cell-based assays in immuno-oncology drug discovery.
There are currently no reviews for this product.